These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38884554)

  • 1. Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy.
    Testa F; Carreño E; van den Born LI; Melillo P; Perea-Romero I; Di Iorio V; Risca G; Iodice CM; Pennings RJE; Karali M; Banfi S; Auricchio A; Galimberti S; Ayuso C; Simonelli F
    Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):25. PubMed ID: 38884554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in Usher syndrome: ultra-widefield fundus autofluorescence and optical coherence tomography findings and their correlation with visual acuity and electrophysiology findings.
    Mustafic N; Ristoldo F; Nguyen V; Fraser CL; Invernizzi A; Jamieson RV; Grigg JR
    Doc Ophthalmol; 2020 Dec; 141(3):205-215. PubMed ID: 32240425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history and retinal structure in patients with Usher syndrome type 1 owing to MYO7A mutation.
    Lenassi E; Saihan Z; Cipriani V; Le Quesne Stabej P; Moore AT; Luxon LM; Bitner-Glindzicz M; Webster AR
    Ophthalmology; 2014 Feb; 121(2):580-7. PubMed ID: 24199935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHENOTYPIC CHARACTERISTICS OF ROD-CONE DYSTROPHY ASSOCIATED WITH MYO7A MUTATIONS IN A LARGE FRENCH COHORT.
    Khateb S; Mohand-Saïd S; Nassisi M; Bonnet C; Roux AF; Andrieu C; Antonio A; Condroyer C; Zeitz C; Devisme C; Loundon N; Marlin S; Petit C; Bodaghi B; Sahel JA; Audo I
    Retina; 2020 Aug; 40(8):1603-1615. PubMed ID: 31479088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDH23-Associated Usher Syndrome: Clinical Features, Retinal Imaging, and Natural History.
    de Guimaraes TAC; Robson AG; de Guimaraes IMC; Laich Y; Aychoua N; Wright G; Kalitzeos A; Mahroo OA; Webster AR; Michaelides M
    Invest Ophthalmol Vis Sci; 2024 Jul; 65(8):27. PubMed ID: 39017633
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Sakti DH; Cornish EE; Mustafic N; Zaheer A; Retsas S; Rajagopalan S; Chung CW; Ewans L; McCluskey P; Nash BM; Jamieson RV; Grigg JR
    Ophthalmic Genet; 2021 Dec; 42(6):706-716. PubMed ID: 34289798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outer Retinal Changes Including the Ellipsoid Zone Band in Usher Syndrome 1B due to MYO7A Mutations.
    Sumaroka A; Matsui R; Cideciyan AV; McGuigan DB; Sheplock R; Schwartz SB; Jacobson SG
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT253-61. PubMed ID: 27409480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLINICAL PRESENTATION AND DISEASE COURSE OF USHER SYNDROME BECAUSE OF MUTATIONS IN MYO7A OR USH2A.
    Testa F; Melillo P; Bonnet C; Marcelli V; de Benedictis A; Colucci R; Gallo B; Kurtenbach A; Rossi S; Marciano E; Auricchio A; Petit C; Zrenner E; Simonelli F
    Retina; 2017 Aug; 37(8):1581-1590. PubMed ID: 27828912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundus autofluorescence and optical coherence tomography in relation to visual function in Usher syndrome type 1 and 2.
    Fakin A; Jarc-Vidmar M; Glavač D; Bonnet C; Petit C; Hawlina M
    Vision Res; 2012 Dec; 75():60-70. PubMed ID: 23000274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal disease course in Usher syndrome 1B due to MYO7A mutations.
    Jacobson SG; Cideciyan AV; Gibbs D; Sumaroka A; Roman AJ; Aleman TS; Schwartz SB; Olivares MB; Russell RC; Steinberg JD; Kenna MA; Kimberling WJ; Rehm HL; Williams DS
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):7924-36. PubMed ID: 21873662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics, Clinical Characteristics, and Natural History of PDE6B-Associated Retinal Dystrophy.
    Hashem SA; Georgiou M; Fujinami-Yokokawa Y; Laich Y; Daich Varela M; de Guimaraes TAC; Ali N; Mahroo OA; Webster AR; Fujinami K; Michaelides M
    Am J Ophthalmol; 2024 Jul; 263():1-10. PubMed ID: 38364953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials.
    Galbis-Martínez L; Blanco-Kelly F; García-García G; Ávila-Fernández A; Jaijo T; Fuster-García C; Perea-Romero I; Zurita-Muñoz O; Jimenez-Rolando B; Carreño E; García-Sandoval B; Millán JM; Ayuso C
    Acta Ophthalmol; 2021 Dec; 99(8):922-930. PubMed ID: 33576163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity.
    Duncan JL; Liang W; Maguire MG; Audo I; Ayala AR; Birch DG; Carroll J; Cheetham JK; Esposti SD; Durham TA; Erker L; Farsiu S; Ferris FL; Heon E; Hufnagel RB; Iannaccone A; Jaffe GJ; Kay CN; Michaelides M; Pennesi ME; Sahel JA;
    Am J Ophthalmol; 2020 Nov; 219():87-100. PubMed ID: 32446738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of microvascular abnormalities using OCT angiography in patients with biallelic variants in
    Hagag AM; Mitsios A; Gill JS; Nunez Do Rio JM; Theofylaktopoulos V; Houston S; Webster AR; Dubis AM; Moosajee M
    Br J Ophthalmol; 2020 Apr; 104(4):480-486. PubMed ID: 31266775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
    Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
    Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
    Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
    Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular function and morphologic features in juvenile stargardt disease: longitudinal study.
    Testa F; Melillo P; Di Iorio V; Orrico A; Attanasio M; Rossi S; Simonelli F
    Ophthalmology; 2014 Dec; 121(12):2399-405. PubMed ID: 25097154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morpho-functional correlation of fundus autofluorescence in Stargardt disease.
    Parodi MB; Iacono P; Triolo G; La Spina C; Zucchiatti I; Cicinelli MV; Borrelli E; Manitto MP; Martina E; Bandello F
    Br J Ophthalmol; 2015 Oct; 99(10):1354-9. PubMed ID: 25837607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema.
    Carpineto P; Ciancaglini M; Di Antonio L; Gavalas C; Mastropasqua L
    Retina; 2007 Jan; 27(1):21-9. PubMed ID: 17218911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.